GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zecotek Photonics Inc (OTCPK:ZMSPF) » Definitions » EV-to-EBITDA

Zecotek Photonics (Zecotek Photonics) EV-to-EBITDA : 0.00 (As of Jun. 10, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Zecotek Photonics EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Zecotek Photonics's enterprise value is $0.00 Mil. Zecotek Photonics's EBITDA for the trailing twelve months (TTM) ended in Apr. 2020 was $-1.65 Mil. Therefore, Zecotek Photonics's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Zecotek Photonics's EV-to-EBITDA or its related term are showing as below:

ZMSPF's EV-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 15.52
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-10), Zecotek Photonics's stock price is $1.0E-5. Zecotek Photonics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2020 was $-0.004. Therefore, Zecotek Photonics's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Zecotek Photonics EV-to-EBITDA Historical Data

The historical data trend for Zecotek Photonics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zecotek Photonics EV-to-EBITDA Chart

Zecotek Photonics Annual Data
Trend Jul10 Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.30 -6.92 -8.29 -4.95 -2.68

Zecotek Photonics Quarterly Data
Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.20 -2.68 -2.74 -1.42 -4.19

Competitive Comparison of Zecotek Photonics's EV-to-EBITDA

For the Medical Devices subindustry, Zecotek Photonics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zecotek Photonics's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zecotek Photonics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Zecotek Photonics's EV-to-EBITDA falls into.



Zecotek Photonics EV-to-EBITDA Calculation

Zecotek Photonics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/-1.653
=0.00

Zecotek Photonics's current Enterprise Value is $0.00 Mil.
Zecotek Photonics's EBITDA for the trailing twelve months (TTM) ended in Apr. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zecotek Photonics  (OTCPK:ZMSPF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Zecotek Photonics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.0E-5/-0.004
=At Loss

Zecotek Photonics's share price for today is $1.0E-5.
Zecotek Photonics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Zecotek Photonics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Zecotek Photonics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Zecotek Photonics (Zecotek Photonics) Business Description

Traded in Other Exchanges
N/A
Address
6900 Graybar Road, Unit 2325, Richmond, BC, CAN, V6W 0A5
Zecotek Photonics Inc is in the business of research and development of photonics technologies. The company is focused on creating advanced materials and integrated optoelectronic devices for high-resolution medical imaging, optical precision surgery, and biopharmaceutical research. It operates in three divisions which include Imaging systems, Optronics systems, and 3D display systems with labs located in Canada, Korea, Russia, Singapore, and the U.S.A. The company develops products such as scintillation crystals, solid-state, photodetectors, positron emission tomography scanning components, lasers, and 3D display and 3D printing technologies. These products are used in sectors such as healthcare, scientific and industrial.